Valion Bio Inc (VBIO) — Net Asset Quality Index
Valion Bio Inc (VBIO) has a Net Asset Quality Index of 53.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $31.61 Million minus total liabilities of $14.81 Million yields net assets of $16.80 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Valion Bio Inc (VBIO) total assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Valion Bio Inc Net Asset Quality Index Over Time (2017–2025)
This chart shows how Valion Bio Inc's Net Asset Quality Index has evolved across 7 annual periods from 2017 to 2025. As of December 2025, the index stands at 53.1%, representing net assets of $16.80 Million against total assets of $31.61 Million USD. See working capital position of Valion Bio Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Valion Bio Inc (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Valion Bio Inc from 2017 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see VBIO market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 53.1% | $16.80 Million | $31.61 Million | $14.81 Million | ▼ -37.2 pp |
| 2024 | 90.3% | $2.54 Million | $2.81 Million | $272.00K | ▲ +20.9 pp |
| 2023 | 69.4% | $3.58 Million | $5.16 Million | $1.58 Million | ▲ +7.6 pp |
| 2022 | 61.8% | $3.63 Million | $5.88 Million | $2.25 Million | ▼ -34.5 pp |
| 2020 | 96.3% | $863.39K | $896.83K | $33.44K | ▲ +46.3 pp |
| 2019 | 50.0% | $1.28 Million | $2.57 Million | $1.28 Million | ▲ +2.3 pp |
| 2017 | 47.7% | $322.27K | $675.79K | $353.52K | — |